So they've diluted another 22.3 million shares since the close of business on December 2 - last Wednesday. What do you think of this in light of their comments in the BioMed article today about "no discussion" about dilution? Any thoughts where these 22.3 million shares came from?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.